Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Swedish authorities issue first approval for next-generation PPI

March 15, 2000

SangStat presents new antiinflammatory candidate RDP-58

March 15, 2000

Italian research institute searches for new enzyme-inhibitory antiviral agents

March 14, 2000

Enteric-coated methylnaltrexone efficiently prevents GI effects of morphine in humans

March 13, 2000

Alizyme reports successful completion of phase I trial for IBD therapy

March 13, 2000

Yamanouchi begins rolling out Infergen in new markets

March 9, 2000

Patent covering novel HCV discovery issued to Chiron

March 7, 2000

C5 inhibitor prevents organ damage associated with GI ischemia in preclinical studies

March 6, 2000

Prepulsid labeling revised in Canada

March 6, 2000

ISIS-14803 begins phase I/II evaluation as HCV treatment

March 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...